NF90/NFAR (nuclear factors associated with dsRNA) – a new methylation substrate of the PRMT5-WD45-RioK1 complex
Author:
Cox Jan1, Esser Lea Marie1, Jüdt Maximilian1, Schmitz Katharina1, Reiffert Kaja1, Grimmler Matthias23, Stork Björn1, Wesselborg Sebastian1, Peter Christoph1
Affiliation:
1. Institute of Molecular Medicine I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf , D-40225 Düsseldorf , Germany 2. Hochschule Fresenius gGmbH, University of Applied Sciences , Limburger Straße 2, D-65510 Idstein , Germany 3. DiaSys Diagnostic Systems GmbH , Alte Strasse 9, D-65558 Holzheim , Germany
Abstract
Abstract
Protein-arginine methylation is a common posttranslational modification, crucial to various cellular processes, such as protein-protein interactions or binding to nucleic acids. The central enzyme of symmetric protein arginine methylation in mammals is the protein arginine methyltransferase 5 (PRMT5). While the methylation reaction itself is well understood, recruitment and differentiation among substrates remain less clear. One mechanism to regulate the diversity of PRMT5 substrate recognition is the mutual binding to the adaptor proteins pICln or RioK1. Here, we describe the specific interaction of Nuclear Factor 90 (NF90) with the PRMT5-WD45-RioK1 complex. We show for the first time that NF90 is symmetrically dimethylated by PRMT5 within the RG-rich region in its C-terminus. Since upregulation of PRMT5 is a hallmark of many cancer cells, the characterization of its dimethylation and modulation by specific commercial inhibitors in vivo presented here may contribute to a better understanding of PRMT5 function and its role in cancer.
Funder
Comprehensive Cancer Center Düsseldorf/Deutsche Krebshilfe Deutsche Forschungsgemeinschaft
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference32 articles.
1. Antonysamy, S., Bonday, Z., Campbell, R.M., Doyle, B., Druzina, Z., Gheyi, T., Han, B., Jungheim, L.N., Qian, Y., Rauch, C., et al.. (2012). Crystal structure of the human PRMT5:MEP50 complex. Proc. Natl. Acad. Sci. U.S.A. 109: 17960–17965, https://doi.org/10.1073/pnas.1209814109. 2. Bedford, M.T. and Clarke, S.G. (2009). Protein arginine methylation in mammals: who, what, and why. Mol. Cell 33: 1–13, https://doi.org/10.1016/j.molcel.2008.12.013. 3. Blanc, R.S. and Richard, S. (2017). Arginine methylation: the coming of age. Mol. Cell 65: 8–24, https://doi.org/10.1016/j.molcel.2016.11.003. 4. Bottger, A., Islam, M.S., Chowdhury, R., Schofield, C.J., and Wolf, A. (2015). The oxygenase Jmjd6--a case study in conflicting assignments. Biochem. J. 468: 191–202, https://doi.org/10.1042/bj20150278. 5. Chan-Penebre, E., Kuplast, K.G., Majer, C.R., Boriack-Sjodin, P.A., Wigle, T.J., Johnston, L.D., Rioux, N., Munchhof, M.J., Jin, L., Jacques, S.L., et al.. (2015). A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models. Nat. Chem. Biol. 11: 432–437, https://doi.org/10.1038/nchembio.1810.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|